These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12485814)

  • 1. Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy.
    Bronzwaer JG; Heymes C; Visser CA; Paulus WJ
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H10-6. PubMed ID: 12485814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.
    Heymes C; Vanderheyden M; Bronzwaer JG; Shah AM; Paulus WJ
    Circulation; 1999 Jun; 99(23):3009-16. PubMed ID: 10368118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart.
    Bronzwaer JG; Zeitz C; Visser CA; Paulus WJ
    Cardiovasc Res; 2002 Aug; 55(2):270-8; discussion 225-8. PubMed ID: 12123766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic dilated cardiomyopathy--a comparison of focal and interstitial fibrosis.
    Yamada T; Hirashiki A; Cheng XW; Okumura T; Shimazu S; Okamoto R; Shinoda N; Isobe S; Takeshita K; Naganawa S; Kondo T; Murohara T
    J Card Fail; 2013 Aug; 19(8):557-64. PubMed ID: 23910585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
    J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nitric oxide in the failing heart.
    Paulus WJ
    Heart Fail Rev; 2001 Mar; 6(2):105-18. PubMed ID: 11309529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure.
    Vanderheyden M; Bartunek J; Knaapen M; Kockx M; De Bruyne B; Goethals M
    J Heart Lung Transplant; 2004 Jun; 23(6):723-8. PubMed ID: 15366433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
    Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
    J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
    Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
    Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft.
    Paulus WJ; Kästner S; Pujadas P; Shah AM; Drexler H; Vanderheyden M
    Circulation; 1997 Nov; 96(10):3436-42. PubMed ID: 9396439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
    Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
    J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
    Sam F; Sawyer DB; Xie Z; Chang DL; Ngoy S; Brenner DA; Siwik DA; Singh K; Apstein CS; Colucci WS
    Circ Res; 2001 Aug; 89(4):351-6. PubMed ID: 11509452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans.
    Kalra DK; Zhu X; Ramchandani MK; Lawrie G; Reardon MJ; Lee-Jackson D; Winters WL; Sivasubramanian N; Mann DL; Zoghbi WA
    Circulation; 2002 Apr; 105(13):1537-40. PubMed ID: 11927517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.